NPM1 represents the most frequently mutated gene in acute myeloid leukemia (AML), accounting for 30% of AML cases, and traditionally confers a better prognosis, although this depends on the pattern of co-mutated genes in the specific patient [1]. Here, NPM1 is linked to acute myeloid leukemia.